NEW YORK (GenomeWeb News) – Myriad Genetics said today that Mammography Reporting Systems, a breast cancer tracking and reporting software service, will use risk markers to identify patients who might benefit from Myriad's BRACAnalysis test.

Myriad said that MRS will incorporate risk factors for hereditary breast cancer risk in its software, enabling more physicians at mammography screening centers to identify patients who may benefit from the Myriad test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.